Exhibit 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In  connection  with the  Quarterly  Report  of  CytoGenix,  Inc.  (the
"Company")  on Form 1O-Q for the period ended  September  30, 2008 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Lex
M. Cowsert, Ph.D., certify,  pursuant to 18 U.S.C. ss. 1350, as adopted pursuant
to ss. 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

     (1)The  Report fully  complies  with the  requirements  of section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)The information contained in the Report fairly presents, in all material
     respects, the financial condition and result of operations of the Company.

November 19, 2008

/s/ Lex M. Cowsert, Ph.D.
- ------------------------
Lex M. Cowsert, Ph.D.
Chief Executive Officer
(Appointed November 14, 2008)